COVID-19 in Children Seminar Series: COVID and the Heart

Friday, December 11, 2020, 12:00 AM - Sunday, December 11, 2022, 12:00 AM PST

Internet Enduring Material sponsored by the Stanford University School of Medicine.

Review of the article “Assessment of 135794 Pediatric patients tested for severe acute respiratory syndrome Coronavirus 2 across the US”. Other topics: COVID-19 and Myocarditis in Children. Discussed the clinical definition of Myocarditis, symptoms, testing, diagnosis, cardiovascular involvement in COVID-19, pathophysiology of cardiac COVID-19. Reviewed cases of COVID-19 and myocarditis. Other topics included: return to exercise after COVID-19, including considerations for when to return to play? How severe was the infection? When was the infection? What is the sport or activity being considered? Review algorithm developed by the American College of Cardiology and based on the article, Return to Play for Athletes After Coronavirus disease 2019 Infection, Making High Stakes Recommendations as Data Evolve.

https://jamanetwork.com/journals/jamacardiology/fullarticle/2772398

Summary points: Most pediatric patients can be cleared for return to play without extensive cardiac testing, return to play should be gradual, despite the appearance of full recovery, patients should be monitored during the first month for any new symptoms concerning cardiac injury or MIS-C.

  Release Date: December 11, 2020
  Review Date: September 8, 2021
  Expiration Date: December 11, 2022
  Estimated Time to Complete: 1 hour
  CME Credits Offered: 1
  Registration Fee: FREE

*Originally recorded 12/03/2020.

Other activities in this series:
Health Disparities and Racism in the Time of COVID
Pediatric Epidemiology and Transmission of COVID-19
COVID-19 and the Primary Care Perspective
COVID-19 in Children: A Conversation 
COVID-19 Vaccines: Development, Trials, Safety & Implications for Children
COVID and Our Schools: Navigating Complex Trade Offs
Peeling Back the Envelope of SARS-CoV-2: Pathogenesis and Immunity
Covid Therapeutics
COVID-19 Open Forum

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Participation Credit (1.00 hours)

1. Evaluate children presenting with COVID-19 who also display symptoms of myocarditis.
2. Develop strategies to return children to athletic activities, post COVID-19 based on current algorithms.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

American Medical Association (AMA)
Stanford Medicine designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008. 

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: http://lane.stanford.edu/portals/cultural.html

Reference/Bibliography List
COVID-19 CME Resources https://med.stanford.edu/cme/COVID19.html

The Stanford University School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education.   There are no relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity.